ClinicalTrials.gov
ClinicalTrials.gov Menu

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01371981
Recruitment Status : Active, not recruiting
First Posted : June 13, 2011
Last Update Posted : October 18, 2018
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)